CSN Login
Members Online: 11

You are here

Trial just started for bone-mestastatic p.cancer in Chicago

Posts: 58
Joined: Sep 2009


Safety and Efficacy Study of KX2-391 in Patients With Bone-Metastatic, Castration-Resistant Prostate Cancer Who Have Not Received Prior Chemotherapy

This study is currently recruiting participants.

Verified by Kinex Pharmaceuticals, LLC, February 2010
First Received: February 22, 2010

Please refer to this study by its ClinicalTrials.gov identifier: NCT01074138

Contact: Laura Dalfonso 716-881-7549 ldalfonso@ahrminc.com
Contact: Lyn Dyster, Ph.D. 716-881-8972 ldyster@kinexpharma.com

United States, Illinois
University of Chicago Recruiting
Chicago, Illinois, United States, 60637
Contact: Beth Manchen, MS, RN 773-702-4135 emanchen@medicine.bsd.uchicago.edu
Principal Investigator: Edwin Posadas, MD

find more info at: http://www.clinicaltrials.gov/ct2/show/NCT01074138

randy_in_indy's picture
Posts: 495
Joined: Oct 2009

This is certainly information someone might really use.

Randy In Indy

Subscribe to Comments for "Trial just started for bone-mestastatic p.cancer in Chicago"